Molecular Characterization and Regulation of GTP-binding Proteins
Molecular Characterization and Regulation of GTP-binding Proteins
批准号:
7734944
负责人:
Martha Vaughan
金额:
$166.54万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
AntibodiesApoptosisBase SequenceBinding ProteinsBrefeldin ACell Cycle ArrestCell NucleolusCell NucleusCell physiologyCellsCleaved cellCommunicationComplexCultured CellsCyclic AMPCyclic AMP-Dependent Protein KinasesDNADataDeoxyribonuclease IDeoxyribonucleasesDistalElevationEndopeptidasesEndoplasmic ReticulumG1 PhaseGTP BindingGTP-Binding ProteinsGenesGenetic TranscriptionGenomicsGoalsGolgi ApparatusGuanine Nucleotide Exchange FactorsGuanosine Triphosphate PhosphohydrolasesInvestigationKnockout MiceLabelMammalian CellMembraneMolecularMolecular ChaperonesNuclearNuclear EnvelopeNucleic AcidsOligonucleotidesPancreatic ribonucleasePathway interactionsPeptide HydrolasesPharmaceutical PreparationsPhosphorylationProcessProtein Disulfide IsomeraseProteinsProteolysisProteomicsRNA-Binding ProteinsRegulationReportingResponse ElementsRoleSerumSignal TransductionSiteSmall Interfering RNAStagingStressStructureSystemTertiary Protein StructureTranscriptional ActivationTransport VesiclesU3 small nucleolar RNAUbiquitinationUp-Regulationbasebeta-COPbiological adaptation to stresscalreticulincell growthfibrillarinfollow-upinterestmolecular dynamicsnovelnuclear pore protein p62nucleolinprotein functionprotein misfoldingresponsetraffickingtranscription factor ATF6ubiquitin-protein ligase
中文摘要
布雷菲德菌素A(BFA)是一种药物,可抑制三种哺乳动物鸟嘌呤核苷酸交换蛋白激活ARF,从而阻断特定细胞内位点转运囊泡形成的起始。 BIG1和BIG2在分泌途径中作用于trans-Golgi膜或更晚,而GBF 1主要在早期与cis-Golgi相关。 内质网(ER)功能的扰动可导致未折叠或错误折叠的蛋白质的积累,其引起ER应激和未折叠蛋白反应(UPR),以及ER应激反应元件(ERSE)基因产物的积累。 BFA处理细胞引起ER中蛋白质的积累、ER应激和最终凋亡。 为了评估BFA敏感性GEF在由延长的BFA处理引起的损伤中的参与,通过使用特异性siRNA选择性地耗尽HepG2细胞的BIG1、BIG2或GBF1。 只有GBF1 siRNA显著减缓细胞生长,导致细胞周期停滞在Go/G1期,并导致高尔基体标志物β-COP和GM130分散,而ER结构似乎完整。 GBF 1耗竭也显著增加ER蛋白钙网蛋白和蛋白质二硫键异构酶(PDI)的水平。 蛋白质组学分析鉴定了参与UPR的ER分子伴侣,其在BGF1耗尽的细胞中的量显著增加。 在ER应激时,转录因子ATF6从ER易位到高尔基体,在高尔基体中,其被位点1和位点2蛋白酶S1P和S2P顺序切割成50-kDa形式,其激活ERSE基因的转录。 耗尽GBF 1,而不是BIG 1或BIG 2诱导的迁移S2 P从高尔基体到ER与蛋白水解的ATF 6,然后上调ER伴侣,模仿UPR反应。 由于BIG1和BIG2是哺乳动物细胞中唯一的其他BFA抑制的GEP,它们负责在新蛋白进入运输系统的远端位点激活ARF,因此它们的缺失可能不会像GBF 1耗尽那样迅速引起ER应激。
我们早期的报告(帕迪利亚等人,2004),BIG1积累在无血清的HepG2细胞的核仁中,促使我们在动态核仁结构中鉴定与其相关的分子。 针对BIG1或核仁素的抗体从细胞核共沉淀这两种蛋白质,其通过用RNase A或DNase孵育细胞核而被废除,这表明相互作用依赖于核酸。 用BIG1或核仁素从细胞核免疫沉淀的RNA的32P标记显示了约1000bp的条带。210个碱基,也与U3小核仁(sno)RNA特异性寡核苷酸杂交。 从抗BIG1或核仁素抗体沉淀的材料中克隆的U3 snoRNA cDNA产生了与基因组DNA中相同的核苷酸序列。 后来的分析表明,原纤蛋白,核孔蛋白p62,和镧BIG1和核仁素免疫沉淀的存在。 我们的数据demonstrte,BIG1,核仁素,U3,U3结合蛋白fibrillarin,和RNA结合蛋白La可能共同作用于核复合物,与BIG1在核仁过程中的潜在作用一致。 有证据表明,BIG1和核仁素,但不是fibrillarin,可以与p62在核膜证实了存在的BIG1和核仁素的动态分子复合物中的组成变化,而移动通过细胞核。 BIG1的核功能仍有待确定。
英文摘要
Brefeldin A (BFA) is a drug that inhibits ARF activation by three mammalian guanine nucleotide-exchange proteins and thereby blocks initiation of transport vesicle formation at specific intracellular sites. BIG1 and BIG2 act at trans-Golgi membranes or later in the secretory pathway, whereas GBF1 predominately associated with cis-Golgi at an earlier stage. Pertubation of endoplasmic reticulum (ER) functions can result in accumulation of unfolded or misfolded proteins that causes ER stress and unfolded protein response (UPR), with accumulation of ER stress response element (ERSE) gene products. BFA treatment of cells causes accumulation of proteins in the ER, ER stress, and ultimately apoptosis. To assess involvement of BFA-sensitive GEFs in the damage resulting from prolonged BFA treatment, HepG2 cells were selectively depleted of BIG1, BIG2, or GBF1 by using specific siRNA. Only GBF1 siRNA dramatically slowed cell growth, led to cell-cycle arrest in Go/G1 phase, and caused dispersion of Golgi markers beta-COP and GM130, whereas ER structure appeared intact. GBF1 depletion also significantly increased levels of ER proteins calreticulin and protein disulfide isomerase (PDI). Proteomic analysis identified ER chaperones involved in the UPR that were significantly increased in amounts in BGF1-depleted cells. Upon ER stress, transcription factor ATF6 translocates from the ER to Golgi, where it is sequentially cleaved by site 1 and site 2 proteases, S1P and S2P, to a 50-kDa form that activates transcription of ERSE genes. Depletion of GBF1, but not BIG1 or BIG2 induced relocation of S2P from Golgi to ER with proteolysis of ATF6 followed by up-regulation of ER chaperones, mimicking a UPR response. Because BIG1 and BIG2, the only other BFA-inhibited GEPs in mammalian cells are responsible for ARF activation at sites distal to that of entry of new proteins to the trafficking system, their absence may not cause ER stress as quickly as does GBF1 depletion.
Our earlier report (Padilla et al., 2004) that BIG1 accumulated in nucleoli of serum-deprived HepG2 cells prompted us to identify molecules associated with it in dynamic nucleolar structures. Antibodies against BIG1 or nucleolin coprecipitated both proteins from nuclei, which was abolished by the incubation of nuclei with RNase A or DNase, indicating that the interaction depended on nucleic acids. 32P labeling of RNAs immunoprecipitated from nuclei with BIG1 or nucleolin revealed bands of approx. 210 bases that also hybridized with U3 small nucleolar (sno)RNA-specific oligonucleotides. Clones of U3 snoRNA cDNAs from the material precipitated by antibodies against BIG1 or nucleolin yielded identical nucleotide sequences that also were found in genomic DNA. Later analyses revealed the presence of fibrillarin, nucleoporin p62, and La in BIG1 and nucleolin immunoprecipitates. Our data demonstrte that BIG1, nucleolin, U3, the U3-binding protein fibrillarin, and the RNA-binding protein La may act together in nuclear complexes, consistent with a potential role for BIG1 in nucleolar processes. Evidence that BIG1 and nucleolin, but not fibrillarin, can be present with p62 at the nuclear envelope confirms the presence of BIG1 and nucleolin in dynamic molecular complexes that change in composition while moving through nuclei. Nuclear functions of BIG1 remain to be determined.
期刊论文(28)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Cytohesin-1 in 2001.
细胞粘附素-1,2001 年。
DOI:
10.1006/abbi.2001.2661
发表时间:
2002
期刊:
Archives of biochemistry and biophysics
影响因子:
3.9
作者:
[Moss,Joel, Vaughan,Martha]
通讯作者:
Vaughan,Martha
Identification of lysosomal and Golgi localization signals in GAP and ARF domains of ARF domain protein 1.
ARF 结构域蛋白 1 的 GAP 和 ARF 结构域中溶酶体和高尔基体定位信号的鉴定。
DOI:
10.1128/mcb.20.19.7342-7352.2000
发表时间:
2000
期刊:
Molecular and cellular biology
影响因子:
5.3
作者:
[Vitale,N, Ferrans,VJ, Moss,J, Vaughan,M]
通讯作者:
Vaughan,M
Purification and cloning of a brefeldin A-inhibited guanine nucleotide-exchange protein for ADP-ribosylation factors.
ADP-核糖基化因子的布雷菲德菌素 A 抑制鸟嘌呤核苷酸交换蛋白的纯化和克隆。
DOI:
10.1074/jbc.274.18.12308
发表时间:
1999
期刊:
The Journal of biological chemistry
影响因子:
--
作者:
[Togawa,A, Morinaga,N, Ogasawara,M, Moss,J, Vaughan,M]
通讯作者:
Vaughan,M
BIG1 and BIG2: brefeldin A-inhibited guanine nucleotide-exchange proteins for ADP-ribosylation factors.
BIG1 和 BIG2:布雷菲德菌素 A 抑制 ADP 核糖基化因子的鸟嘌呤核苷酸交换蛋白。
DOI:
10.1016/s0076-6879(02)45032-x
发表时间:
2002
期刊:
Methods in enzymology
影响因子:
--
作者:
[Pacheco-Rodriguez,Gustavo, Moss,Joel, Vaughan,Martha]
通讯作者:
Vaughan,Martha
Cybr, a cytokine-inducible protein that binds cytohesin-1 and regulates its activity.
Cybr,一种细胞因子诱导蛋白,可结合 cytohesin-1 并调节其活性。
DOI:
10.1073/pnas.052712999
发表时间:
2002
期刊:
Proceedings of the National Academy of Sciences of the United States of America
影响因子:
11.1
作者:
[Tang,Pingtao, Cheng,TammyP, Agnello,Davide, Wu,Chang-You, Hissong,BruceD, Watford,WendyT, Ahn,Hyun-Jong, Galon,Jerome, Moss,Joel, Vaughan,Martha, O'Shea,JohnJ, Gadina,Massimo]
通讯作者:
Gadina,Massimo
共 12 条
MOLECULAR AND BIOCHEMICAL CHARACTERIZATION OF GTP-BINDING PROTEIN
-
批准号:6109178
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Martha Vaughan
-
依托单位:
REGULATION OF GTP BINDING PROTEINS
-
批准号:6109175
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Martha Vaughan
-
依托单位:
Molecular Characterization and Regulation of GTP-binding Proteins
-
批准号:7594366
-
项目类别:
-
资助金额:$282.94万
-
财政年份:--
-
负责人:Martha Vaughan
-
依托单位:
GTP-BINDING PROTEIN STRUCTURE/FUNCTION STUDIES
-
批准号:6109176
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Martha Vaughan
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位:
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
-
批准号:39500043
-
项目类别:青年科学基金项目
-
资助金额:9.0万元
-
批准年份:1995
-
负责人:梁克
-
依托单位: